Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

[Breast cancer in Morocco: phenotypic profile of tumors].

Khalil AI, Bendahhou K, Mestaghanmi H, Saile R, Benider A.

Pan Afr Med J. 2016 Oct 6;25:74. doi: 10.11604/pamj.2016.25.74.9966. eCollection 2016. French.

2.

First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases.

Elidrissi Errahhali M, Elidrissi Errahhali M, Ouarzane M, El Harroudi T, Afqir S, Bellaoui M.

BMC Womens Health. 2017 Jan 9;17(1):3. doi: 10.1186/s12905-016-0361-z.

3.

Correlating Tumor Stiffness with Immunohistochemical Subtypes of Breast Cancers: Prognostic Value of Comb-Push Ultrasound Shear Elastography for Differentiating Luminal Subtypes.

Denis M, Gregory A, Bayat M, Fazzio RT, Whaley DH, Ghosh K, Shah S, Fatemi M, Alizad A.

PLoS One. 2016 Oct 24;11(10):e0165003. doi: 10.1371/journal.pone.0165003. eCollection 2016.

4.

Comparison of Pathologic Response Evaluation Systems after Anthracycline with/without Taxane-Based Neoadjuvant Chemotherapy among Different Subtypes of Breast Cancers.

Lee HJ, Park IA, Song IH, Kim SB, Jung KH, Ahn JH, Ahn SH, Kim HH, Gong G.

PLoS One. 2015 Sep 22;10(9):e0137885. doi: 10.1371/journal.pone.0137885. eCollection 2015.

5.

Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study.

Llanos AA, Chandwani S, Bandera EV, Hirshfield KM, Lin Y, Ambrosone CB, Demissie K.

Cancer Causes Control. 2015 Dec;26(12):1737-50. doi: 10.1007/s10552-015-0667-4. Epub 2015 Sep 16.

6.

Role of positron emission tomography for the monitoring of response to therapy in breast cancer.

Humbert O, Cochet A, Coudert B, Berriolo-Riedinger A, Kanoun S, Brunotte F, Fumoleau P.

Oncologist. 2015 Feb;20(2):94-104. doi: 10.1634/theoncologist.2014-0342. Epub 2015 Jan 5. Review.

7.

Distribution of breast cancer subtypes among Jordanian women and correlation with histopathological grade: molecular subclassification study.

Shomaf M, Masad J, Najjar S, Faydi D.

JRSM Short Rep. 2013 Sep 13;4(10):2042533313490516. doi: 10.1177/2042533313490516. eCollection 2013.

8.

Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ.

Aguiar FN, Mendes HN, Cirqueira CS, Bacchi CE, Carvalho FM.

Clinics (Sao Paulo). 2013 May;68(5):638-43. doi: 10.6061/clinics/2013(05)010.

9.

[Molecular classification of breast cancer in Morocco].

Fouad A, Yousra A, Kaoutar Z, Omar el M, Afaf A, Sanae B.

Pan Afr Med J. 2012;13:91. Epub 2012 Dec 31. French. No abstract available.

10.

Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco.

El Fatemi H, Chahbouni S, Jayi S, Moumna K, Melhouf MA, Bannani A, Mesbahi O, Amarti A.

Diagn Pathol. 2012 Dec 7;7:170. doi: 10.1186/1746-1596-7-170. Retraction in: Diagn Pathol. 2013;8:127.

11.

Prevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study.

Bennis S, Abbass F, Akasbi Y, Znati K, Joutei KA, El Mesbahi O, Amarti A.

BMC Res Notes. 2012 Aug 13;5:436. doi: 10.1186/1756-0500-5-436.

12.

Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer.

Morrison DH, Rahardja D, King E, Peng Y, Sarode VR.

Br J Cancer. 2012 Jul 10;107(2):382-7. doi: 10.1038/bjc.2012.219. Epub 2012 Jun 19.

14.
15.

Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients.

Carvalho FM, Bacchi LM, Santos PP, Bacchi CE.

Clinics (Sao Paulo). 2010;65(10):1033-6.

16.

Aberrant expression of LMO4 induces centrosome amplification and mitotic spindle abnormalities in breast cancer cells.

Montañez-Wiscovich ME, Shelton MD, Seachrist DD, Lozada KL, Johnson E, Miedler JD, Abdul-Karim FW, Visvader JE, Keri RA.

J Pathol. 2010 Nov;222(3):271-81. doi: 10.1002/path.2762.

17.

Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.

Moestue SA, Borgan E, Huuse EM, Lindholm EM, Sitter B, Børresen-Dale AL, Engebraaten O, Maelandsmo GM, Gribbestad IS.

BMC Cancer. 2010 Aug 17;10:433. doi: 10.1186/1471-2407-10-433.

18.
19.

Protein expression profile and prevalence pattern of the molecular classes of breast cancer--a Saudi population based study.

Al Tamimi DM, Shawarby MA, Ahmed A, Hassan AK, AlOdaini AA.

BMC Cancer. 2010 May 21;10:223. doi: 10.1186/1471-2407-10-223.

20.

Germline mutations and polymorphisms in the origins of cancers in women.

Hirshfield KM, Rebbeck TR, Levine AJ.

J Oncol. 2010;2010:297671. doi: 10.1155/2010/297671. Epub 2010 Jan 10.

Supplemental Content

Support Center